MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Intermediaries
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Massachusetts
Silicon Therapeutics
Industry: China
Sino Biopharmaceutical Co., Ltd.
LaNova Medicines
Attachments
Home-LaNova Medicines
Parents
Companies: Acquired_(M&A)
Industry: China
Sino Biopharmaceutical Co., Ltd.
Children
2024: Merck Enters into Exclusive Global License for LM-299, An Investigational Anti-PD-1/VEGF Bispecific Antibody from LaNova Medicines Ltd.
2024: Merck, facing threat to Keytruda, buys into new kind of cancer immunotherapy
2025: Sino Biopharma spends $951m to acquire China-based LaNova Medicines
Founded 2019
Shanghai, China
Jumps
Merck & Co., Inc. (NYSE:MRK)